Product Description: Adefovir dipivoxil (Standard) is the analytical standard of Adefovir dipivoxil. This product is intended for research and analytical applications. Adefovir dipivoxil, an adenosine analogue, is an oral proagent of the nucleoside reverse transcriptase inhibitor Adefovir. Adefovir dipivoxil inhibits both the wild type and HBV Lamivudine-resistant strains[1][2]. Adefovir dipivoxil shows anti-orthopoxvirus activity.
Formula: N/A
References: [1]Noble S, et al. Adefovir dipivoxil. Drugs. 1999;58(3):479-489./[2]Buti M, et al. Adefovir dipivoxil. Drugs Today (Barc). 2003;39(2):127-135./[3]Mark N Prichard, et al. Orthopoxvirus targets for the development of antiviral therapies. Curr Drug Targets Infect Disord. 2005 Mar;5(1):17-28.
CAS Number: 142340-99-6
Molecular Weight: N/A
Research Area: Infection; Cancer
Target: Endogenous Metabolite;HBV;Orthopoxvirus;Reverse Transcriptase
English
Deutsch
